Make a Best-in-Class Bispecific Drug

Webinar Details

Recorded on November 16, 2023

Speaker: Josh Apgar, PhD, Co-founder and CSO at Applied BioMath

Abstract: This is an introductory case study showing how Applied BioMath Assess™ can be used early in drug R&D to gain insight into project feasibility. Specifically in this case study, we'll discuss how to account for more complex design considerations and make a best-in-class bispecific drug. You'll learn how to:

  • Set up a model using data on  PD1 and CTLA4
  • Benchmark the model using PK/PD data for Lorigerlimab
  • Identify best in class parameters for a PD1/CTLA4

View the Webinar